Rite Aid and EnvisionRx Collaborate to Improve Medication Adherence and Health Outcomes Through New Rx90 Program
August 17 2016 - 12:33PM
Business Wire
Rx90 Offers Same Price for 90-day Prescriptions
at Nearly 4,600 Rite Aid Pharmacies or via Home Delivery
New Program Leverages Tailored Communications,
Plan Design and Clinical Support to Improve Patient Outcomes; Lower
Benefit Costs for Health Plans and Employers
Rite Aid, one of the nation’s leading drugstore chains, and
EnvisionRx, the pharmacy benefit management (PBM) division of
EnvisionRxOptions and a wholly owned subsidiary of Rite Aid,
announced today the availability of Rx90, a new program focused on
improving medication adherence and health outcomes for consumers
with chronic conditions.
Rx90, now available for EnvisionRx clients, gives consumers the
option to fill their 90-day prescriptions at any of the nearly
4,600 Rite Aid pharmacy locations around the country. For the same
price, consumers also have the option to have their medications
delivered through EnvisionPharmacies’ mail service.
Other benefits of Rx90 include:
- Integrated care and clinical support
from Rite Aid pharmacists and EnvisionRx
- Targeted, disease-specific
communications
- The largest 90-day retail maintenance
medication network (over 12,000 total pharmacies)
- Reduced copays that provide most
members with 15-30 days of free coverage
In addition to providing consumers with improved pricing, more
convenient options on how to fill their 90-day maintenance
medications and additional clinical support, the collaboration
between Rite Aid and EnvisionRx helps to address rising health care
costs. According to a 2014 Towers Watson study of employer provided
health care, the consumer’s share of health care costs, including
premiums and out-of-pocket costs, has grown from 34.4% in 2011 to
37% in 2014, an average increase of about $100 more a month.
“Rite Aid is excited to work with EnvisionRx to bring an
innovative pharmacy solution for consumers, health plans and
employers to market,” said Jocelyn Konrad, Rite Aid executive vice
president of pharmacy. “Rx90 is a great example of how our
pharmacies and PBMs can collaborate to achieve our shared goal of
improving the patient experience and care, while reducing and
managing healthcare costs.”
Using client-specific data and its own research, EnvisionRx is
also able to provide health plans and employers with
recommendations on customizing their benefit design,
communications, and clinical strategies to meet their individual
needs. Rx90 will help plan sponsors better control drug spend and
reduce costly medical expenses associated with increased visits to
physicians and emergency rooms, as well as extended
hospitalizations.
“In today’s market, plan sponsors and their members need a PBM
that truly provides more flexible, affordable options to control
the costs of chronic care. Rx90 and our technology platform give
plan sponsors another way to customize their prescription drug
benefit plan and put actionable, cost saving information in the
hands of their members,” said Frank Sheehy, EnvisionRxOptions
CEO.
Rite Aid Corporation (NYSE: RAD) is one of the nation's leading
drugstore chains with nearly 4,600 stores in 31 states and the
District of Columbia and fiscal 2016 annual revenues of $30.7
billion. Information about Rite Aid, including corporate background
and press releases, is available through the company's website at
www.riteaid.com.
EnvisionRx is a division of EnvisionRxOptions, a health care
company with a visibly different approach to managing pharmacy
benefits. As a full service provider, Envision leverages its core
PBM services including Mail, Specialty and Compounding Pharmacies;
Part D Medicare insurance plans; and cash savings programs, to help
employers and health plans of all sizes provide more affordable and
effective prescription drug coverage for their members.
Headquartered in Twinsburg, Ohio, EnvisionRxOptions is a wholly
owned subsidiary of Rite Aid. For more information, visit
www.envisionrxoptions.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160817006031/en/
Rite AidINVESTORS:Matt Schroeder,
717-214-8867investor@riteaid.comorMEDIA:Ashley Flower,
717-975-5718orEnvisionRxOptionsMEDIA:Bobby Creek,
813-690-8503bcreek@envisionrx.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2024 to May 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From May 2023 to May 2024